Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines

被引:0
|
作者
Osada, H [1 ]
Tatematsu, Y [1 ]
Masuda, A [1 ]
Saito, T [1 ]
Sugiyama, M [1 ]
Yanagisawa, K [1 ]
Takahashi, T [1 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor (TGF)-beta strongly inhibits epithelial cell proliferation. Alterations of TGF-beta signaling are thought to play a role in tumorigenesis. We show in the present study that most lung cancer cell lines have lost the growth-inhibitory response to TGF-beta signal, and that those with TGF-beta unresponsiveness can be divided into two major groups, TGF-beta type II receptor (TGF beta RII)(+)/Smad7(+) and TGF beta RII(-)/Smad7(-), suggesting the heterogeneous mechanisms underlying the TGF-beta responsiveness. The mechanism of the loss of TGF beta RII expression of the latter group was further studied, identifying aberrant DNA methylation of the promoter region in a limited fraction of cell lines. Interestingly, we found that the alteration of chromatin structure because of histone deacetylation may also be involved, showing a good correlation with loss of TGF beta RII expression. This notion was supported by the findings of a restriction enzyme accessibility assay, of a chromatin immunoprecipitation assay with anti-acetyl historic antibodies, and of an in vivo induction of TGF beta RII expression by histone deacetylase inhibitors including trichostatin A (TSA) and sodium butyrate. In vitro induction of TGF beta RII promoter reporter activity by TSA was also detected and found to require the CCAAT box within the -127/-75 region. A positive regulatory mechanism for TGF beta RII expression in a TGF-beta -expressing cell line was also investigated, and a TPA-responsive element (TRE)-like motif, TRE2, was detected in addition to the previously reported TRE-like motif Y element in the positive regulatory region. Alterations in two discrete proteins interacting with these two TRE-like motifs were also suspected of being involved in the loss of TGF beta RII expression. This is the first study to demonstrate that, in addition to the TSA-responsive region and TRE2 motif in the TGF beta RII promoter, the alteration of histone deacetylation may be involved in the loss of TGF beta RII expression in lung cancer cell lines.
引用
收藏
页码:8331 / 8339
页数:9
相关论文
共 50 条
  • [41] Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines
    Hougaard, S
    Norgaard, P
    Abrahamsen, N
    Moses, HL
    Spang-Thomsen, M
    Poulsen, HS
    BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) : 1005 - 1011
  • [42] Histone Deacetylase Inhibitor Belinostat Represses Survivin Expression through Reactivation of Transforming Growth Factor β ( TGFβ) Receptor II Leading to Cancer Cell Death
    Chowdhury, Sanjib
    Howell, Gillian M.
    Teggart, Carol A.
    Chowdhury, Aparajita
    Person, Jonathan J.
    Bowers, Dawn M.
    Brattain, Michael G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (35) : 30937 - 30948
  • [43] Loss of functional transforming growth factor (TGF)-β type II receptor results in insensitivity to TGF-β1-mediated apoptosis and Epstein-Barr virus reactivation
    Fukuda, Makoto
    Kurosaki, Hajime
    Sairenji, Takeshi
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (11) : 1456 - 1464
  • [44] Mutant p53 attenuates the SMAD-dependent transforming growth factor β1 (TGF-β1) signaling pathway by repressing the expression of TGF-β receptor type II
    Kalo, Eyal
    Buganim, Yosef
    Shapira, Keren E.
    Besserglick, Hilla
    Goldfinger, Naomi
    Weisz, Lilach
    Stambolsky, Perry
    Henis, Yoav I.
    Rotter, Varda
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (23) : 8228 - 8242
  • [45] Soluble transforming growth factor β type II receptor attenuates TGF-β1 activity in human colorectal cancer LoVo cells
    Zhou, Rui
    Xiong, Bin
    Song, Haibin
    Liu, Shiquan
    Wang, Xinbo
    ONCOLOGY REPORTS, 2008, 20 (06) : 1449 - 1456
  • [46] Resistance to TGF-β1 correlates with aberrant expression of TGF-β receptor II in human B-cell lymphoma cell lines
    Chen, Gang
    Ghosh, Paritosh
    Osawa, Hiroshi
    Sasaki, Carl Y.
    Rezanka, Louis
    Yang, Jiandong
    O'Farrell, Thomas J.
    Longo, Dan L.
    BLOOD, 2007, 109 (12) : 5301 - 5307
  • [47] Transforming growth factor β (TGF-β)-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-β function
    Wang, SE
    Wu, FY
    Shin, I
    Qu, SM
    Arteaga, CL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (11) : 4703 - 4715
  • [48] Soluble type II transforming growth factor-β (TGF-β) receptor inhibits TGF-β signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation
    Rowland-Goldsmith, MA
    Maruyama, H
    Kusama, T
    Ralli, S
    Korc, M
    CLINICAL CANCER RESEARCH, 2001, 7 (09) : 2931 - 2940
  • [49] Glucocorticoid up-regulates transforming growth factor-β (TGF-β) type II receptor and enhances TGF-β signaling in human prostate cancer PC-3 cells
    Li, Zongbin
    Chen, Yuxia
    Cao, Dongmei
    Wang, Yan
    Chen, Guangchun
    Zhang, Shimin
    Lu, Jian
    ENDOCRINOLOGY, 2006, 147 (11) : 5259 - 5267
  • [50] Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy -: Amelioration by soluble TGF-β type II receptor
    Russo, Leileata M.
    del Re, Elisabetta
    Brown, Dennis
    Lin, Herbert Y.
    DIABETES, 2007, 56 (02) : 380 - 388